(04/29) Interesting Stocks Today - With Wegovy, nothing is HIMS-possible

This is a daily watchlist for short-term trading: I might trade all/none of the stocks listed, and even stocks not listed! I am targeting potentially good candidates for short-term trading; I have no opinion on them as investments. The potential of the stock moving today is what makes it interesting, everything else is secondary.

We're back baby.

News: [GM Suspends Guidance Freezes Share Buyback on Trump Tariffs](https://www.bloomberg.com/news/articles/2025-04-29/gm-suspends-guidance-freezes-share-buyback-on-trump-tariffs)

[**HIMS (HIMS Health)**](https://finviz.com/quote.ashx?t=HIMS&p=d)/[**NVO (Novo Nordisk)**](https://finviz.com/quote.ashx?t=NVO&p=d) \- Novo Nordisk opened access to Wegovy through telehealth channels, moving all the telehealth names up incrementally. HIMS jumped 30% - the legal repercussions seem more of a major driver instead of the drug itself to me, driven by the opportunity to distribute weight loss solutions via its platform. I'm interested mainly in the $38/$40 levels. Regulatory pushback regarding online prescriptions for GLP-1s is gone, especially with the compounding issues (mentioned last week). Supply constraints are the main bottleneck now.

[**GM (General Motors)**](https://finviz.com/quote.ashx?t=GM&p=d) \- GM suspended its 2024 guidance and halted its $10B buyback program amid concerns over potential tariffs. Reported EPS of $2.78 vs $2.74 expected and revenue of $44.02B vs $43.05B expected. The auto sector faces renewed uncertainty as tariff threats return to the forefront, impacting cost structures and global production strategies. At this point, more interested in the down-side potential because escalating tariffs would slaughter margins.

[**SOFI (SoFi Technologies)**](https://finviz.com/quote.ashx?t=SOFI&p=d) \- Beat on earnings with $0.06 EPS vs $0.03 expected and revenue of $772M vs $739M expected. Added 800K new members; tech platform revenue grew +10% YoY, financial services +100% YoY, lending +25% YoY, and increased FY25 guidance by $85M with EPS raised by 2 cents. Interested in $14.50 level. Increased regulatory scrutiny around fintech lending practices, along with margin compression if rate cuts accelerate. Unlikely to happen unless Powell changes his mind.

[**PLTR (Palantir Technologies)**](https://finviz.com/quote.ashx?t=PLTR&p=d) \- One of the steadiest runs I've seen, news attributes it to expanded government contracts and department overhauls. Watching $113/$115 levels closely; no bias either way, the move is steady. Likely going to go for a minor short if we turn strongly, but will keep tight stops in this one.

**Earnings today:** V,SBUX,SNAP,FSLR